Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats

[1]  L. Dwoskin,et al.  Lobeline Displaces [3H]Dihydrotetrabenazine Binding and Releases [3H]Dopamine from Rat Striatal Synaptic Vesicles: Comparison with d‐Amphetamine , 1998, Journal of neurochemistry.

[2]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[3]  S. Wonnacott,et al.  Differential Inhibition by α‐Conotoxin‐MII of the Nicotinic Stimulation of [3H]Dopamine Release from Rat Striatal Synaptosomes and Slices , 1998, Journal of neurochemistry.

[4]  P. Bickler,et al.  Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. , 1997, Molecular pharmacology.

[5]  A. Beaudet,et al.  Mice Deficient in the α7 Neuronal Nicotinic Acetylcholine Receptor Lack α-Bungarotoxin Binding Sites and Hippocampal Fast Nicotinic Currents , 1997, The Journal of Neuroscience.

[6]  John T. Williams,et al.  Nicotine activates and desensitizes midbrain dopamine neurons , 1997, Nature.

[7]  G. Di Chiara,et al.  Effects of Cocaine and Morphine in Rats from Two Psychogenetically Selected Lines: A Behavioral and Brain Dialysis Study , 1997, Behavior genetics.

[8]  M. Damaj,et al.  Pharmacology of lobeline, a nicotinic receptor ligand. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[10]  E X Albuquerque,et al.  Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. , 1997, The Journal of pharmacology and experimental therapeutics.

[11]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[12]  G. Chiara,et al.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.

[13]  J. Brioni,et al.  Nicotine cue: lack of effect of the α7 nicotinic receptor antagonist methyllycaconitine , 1996 .

[14]  S. Arneric,et al.  Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. , 1995, Life sciences.

[15]  M. Benwell,et al.  Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine , 1995, British journal of pharmacology.

[16]  P. Rowell,et al.  Characterization of Nicotine‐Induced Desensitization of Evoked Dopamine Release from Rat Striatal Synaptosomes , 1994, Journal of neurochemistry.

[17]  A. C. Collins,et al.  Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes , 1994, Journal of neurochemistry.

[18]  T. Svensson,et al.  Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area , 1994, Synapse.

[19]  S. Arneric,et al.  Effects of lobeline, a nicotinic receptor agonist, on learning and memory , 1993, Pharmacology Biochemistry and Behavior.

[20]  J. Patrick,et al.  Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  P. Whiting,et al.  Three subtypes of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  A. C. Collins,et al.  Characterization of Nicotinic Receptor‐Mediated [3H]Dopamine Release from Synaptosomes Prepared from Mouse Striatum , 1992, Journal of neurochemistry.

[23]  A. C. Collins,et al.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  M. Benwell,et al.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity , 1992, British journal of pharmacology.

[25]  Zhong-Wei Zhang,et al.  Nicotinic receptors that bind α-bungarotoxin on neurons raise intracellular free ca2+ , 1992, Neuron.

[26]  J. Patrick,et al.  Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors , 1992, Neuron.

[27]  A. C. Collins,et al.  Regulation of Brain Nicotinic Receptors by Chronic Agonist Infusion , 1991, Journal of neurochemistry.

[28]  J. Gray,et al.  Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen , 1990, Neuropharmacology.

[29]  B. Testa,et al.  Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline , 1990, Neuropharmacology.

[30]  Luis Hernandez,et al.  Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis , 1989, Brain Research.

[31]  P. Jenner,et al.  High affinity binding of [3H] (−)-nicotine to rat brain membranes and its inhibition by analogues of nicotine , 1988, Neuropharmacology.

[32]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[33]  S. Wonnacott.  α‐Bungarotoxin Binds to Low‐Affinity Nicotine Binding Sites in Rat Brain , 1986 .

[34]  P. Fudala,et al.  Further studies on nicotine-induced conditioned place preference in the rat , 1986, Pharmacology Biochemistry and Behavior.

[35]  R. D. Schwartz,et al.  In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs , 1985, Journal of neurochemistry.

[36]  E. Albuquerque,et al.  The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. , 1985, Molecular pharmacology.

[37]  A. C. Collins,et al.  Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. , 1982, Molecular pharmacology.

[38]  S. Arneric,et al.  The pharmacology of (-)-nicotine and novel cholinergic channel modulators. , 1997, Advances in pharmacology.

[39]  J. Lindstrom,et al.  Neuronal nicotinic acetylcholine receptors. , 1996, Ion channels.

[40]  L. Role,et al.  Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. , 1995, Annual review of physiology.

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .